Los mejores médicos de Orquiectomia del mundo — TOP 33

El Dr. Bugra Cetin, MD, PhD, es un urólogo certificado. Se especializa en cirugía de prótesis peneana, reconstrucción genital y salud sexual masculina. Ha realizado cientos de implantes y procedimientos reconstructivos, con altos índices de satisfacción y seguridad entre sus pacientes.

El Dr. Cetin emplea técnicas quirúrgicas avanzadas para tratar la disfunción eréctil, la enfermedad de Peyronie y la eyaculación precoz. Es experto en implantes inflables y maleables, escisión de placas, injertos y denervación peneana. También realiza cirugías uro-oncológicas, endourológicas y reconstructivas, logrando excelentes resultados en casos complejos.

El Dr. Cetin está acreditado por la IICPI y tiene un doctorado en Medicina Molecular. Es miembro activo de la ISSM, ESSM, EAU y la Asociación Turca de Urología, lo que refleja su compromiso con la excelencia e innovación en urología.

Urólogo certificado especializado en salud sexual masculina y procedimientos mínimamente invasivos en Menness Wellness Clinic.

• Especializado en andrología y procedimientos reconstructivos
• Experto en cirugía testicular y reconstrucción escrotal
• Brinda atención centrada en el paciente enfocada en la calidad de vida
• Ofrece procedimientos urológicos de afirmación de género

El Dr. Tanongsak Panyawirunroj es un destacado cirujano plástico en el Asia Cosmetic Hospital de Bangkok. Ha realizado más de 15,000 operaciones a lo largo de su carrera. El Dr. Tanongsak se especializa en procedimientos transformadores como la rinoplastia y la cirugía de reasignación sexual. Completó becas en EE. UU., Canadá, Corea del Sur y Taiwán.

• Representante oficial de la Sociedad Coreana de Cirujanos Plásticos.
• Miembro de la Sociedad Internacional de Cirugía Plástica Estética (ISAPS).
• Realiza cirugías complejas de feminización facial (FFS) y cirugías ortognáticas.
• Practica en un centro acreditado por la JCI con una tasa de complicaciones postoperatorias del 0%.

El médico se graduó de la Facultad de Medicina de la Universidad 19 Mayıs en 1994 y completó una residencia en el Hospital de Enseñanza e Investigación de Taksim en 2002. El médico ha contribuido a numerosas revistas internacionales y locales, mostrando experiencia en los campos de endourología, urología pediátrica, urooncología, andrología e infertilidad. El médico ha trabajado en varios centros de salud y hospitales, incluyendo el Centro de Salud Ayvacik del Ministerio de Salud de Turquía, el Centro de Salud Carsamba en Samsun, el Hospital de Enseñanza e Investigación de Taksim y el Hospital Estatal Şebinkarahisar en Giresun.<\/p>

El Dr. Cenk Acar es cirujano urólogo en el Hospital Hisar Intercontinental de Estambul. Ha realizado más de 500 cirugías de cáncer urológico. Fue el primer médico en Turquía en aplicar la enucleación prostática bipolar. El Dr. Acar completó una beca en cirugía robótica y laparoscópica en el Instituto del Cáncer de los Países Bajos.

• Realizó más de 250 procedimientos HOLEP para el agrandamiento benigno de la próstata.
• Experto en imágenes de fluorescencia intraoperatoria para cirugías urológicas robóticas.
• Especializado en disecciones de ganglios linfáticos centinela para el tratamiento del cáncer de próstata.
• Trabaja en un hospital acreditado por la JCI que atiende a 500,000 pacientes al año.

El Dr. Mehmet Sarier es urólogo y andrólogo en el Hospital Medical Park Antalya. Es miembro de la facultad de Medicina de la Universidad Istinye. El Dr. Sarier se especializa en infertilidad masculina, salud sexual y cirugía robótica. Ostenta el rango de profesor asociado desde 2020.

• Realiza prostatectomías y nefrectomías robóticas da Vinci.
• Utiliza terapia con células madre para tratar la disfunción eréctil y la infertilidad masculina.
• Trata afecciones complejas como varicocele, azoospermia y enfermedad de Peyronie.
• Ejerce en el hospital privado más grande de la región mediterránea.

Jefe de Oncología de Tejidos Blandos y Huesos en el Centro Médico Sourasky – especializado en casos complejos de sarcoma con 41 años de experiencia enfocada.

• Formación especializada en el Institut Gustave Roussy de París para el tratamiento del sarcoma
• Miembro de la facultad de la ESMO para sarcoma y oncología ósea
• Amplias publicaciones sobre resultados en oncología ortopédica
• Dirige comités éticos para protocolos de tratamiento del cáncer

Especialista en cáncer testicular: el Dr. Solak completó su especialización en el Instituto del Cáncer de la Universidad de Hacettepe.

• Más de una década de experiencia en el tratamiento del cáncer testicular
• Formado en el MD Anderson Cancer Center, uno de los mejores hospitales oncológicos
• Trabaja en el Hisar Hospital Intercontinental
• Miembro del Instituto del Cáncer de la Universidad de Hacettepe

El Dr. Alejandro Lira es un urólogo con amplia experiencia en Tijuana, Baja California, México. Obtuvo el título de médico por la Universidad de Guadalajara en 2005. Realizó la especialidad en Urología en la UNAM, en la Ciudad de México, y recibió la certificación como cirujano en 2011.

Es miembro del Consejo Mexicano de Urología. Asiste regularmente a eventos de urología. Tras certificarse, regresó a Tijuana y trabaja con hospitales en toda la ciudad.

Es originario de Tijuana y habla inglés. Está disponible para consultas y atención quirúrgica, previa revisión de los informes médicos.

Especialista en oncología ginecológica y cirugías laparoscópicas – experto en técnicas sin cicatrices y mínimamente invasivas.

• Experto en procedimientos V-Notes y laparoscópicos
• Realiza cirugías histeroscópicas para el tratamiento de pólipos y tabiques
• Especializado en el seguimiento y cirugía de la endometriosis

El Dr. Alam Bouhaouli es cirujano urólogo en la clínica KCM de Polonia. Se especializa en el tratamiento quirúrgico de afecciones del pene, la próstata y los riñones. El Dr. Bouhaouli utiliza técnicas microscópicas y láser para intervenciones de alta precisión. Trata casos oncológicos complejos junto con trastornos urológicos generales.

• Realiza reversiones de vasectomía microquirúrgicas y cirugía de varicocele.
• Especializado en vaporización prostática endoscópica mediante el sistema Olympus TURIS-P.
• Realiza extirpaciones laparoscópicas de riñón y próstata en un centro con certificación ISO.
• Ofrece tratamientos especializados para la curvatura del pene y la incontinencia urinaria.

El Dr. Murat B. es especialista en Cirugía Plástica, Reconstructiva y Estética. Trabaja en Grand Clinic, en Estambul. Cuenta con la certificación de la Sociedad Turca de Cirugía Plástica, Reconstructiva y Estética. Fue responsable de la Unidad de Quemados del Hospital Estatal Atatürk de Zonguldak.

Áreas de interés clínico: rinoplastia, liposucción y contorno corporal, cirugía mamaria (aumento, reducción), cirugía facial, blefaroplastia y cirugía del mentón.

La Prof. Selin Kapan es profesora de cirugía general con más de _doctor_10984_ años de experiencia, especializada en procedimientos quirúrgicos complejos en el İstinye University Liv Hospital Topkapı.

• Autora de más de 50 publicaciones científicas en campos quirúrgicos
• Miembro de múltiples asociaciones quirúrgicas prestigiosas, incluida la Asociación Quirúrgica Turca
• Especializada en técnicas quirúrgicas mínimamente invasivas y laparoscópicas
• Amplia experiencia en cirugía de urgencias y traumatología

Zhang Jinshan, male, China’s First M.D. in the Radiation Medicine, CCI (Chinese College of Interventionalists) Master Interventionalist, Director of the Department of Former Radiological Diagnosis at Chinese PLA General Hospital(No.3 in China) Ph.D. of Medicine, Nagasaki University, Japan.

1980–1985: Completed doctoral studies at Nagasaki University, Japan

1968–present: Department of Radiology, Chinese PLA General Hospital

1988: Third Prize of the Military Science and Technology Progress Award

1989–present: Member of Radiological Society of North America(RSNA)

1990–2009: Standing Committee Member of the Radiology and Therapeutic Radiology Committee of the PLA

1991: Second Prize of the Military Science and Technology Progress Award

1992–2008: Group Leader of the Group of Intervention of Chinese Journal of Radiology

1992–2015: Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

1993: Granted the Lifetime Special Government Allowance of the State Council

1993–2012: Deputy Chief Editor of Chinese Journal of Medical Image Technology

1994: Third Prize of the Military Science and Technology Progress Award

1997: Second Prize of the Military Science and Technology Progress Award

1997–2009: Standing Member of Chinese Society of Radiology

1999: Third Prize of the Military Science and Technology Progress Award

1999–2010: Deputy Director Member of Chinese Society of Interventional Oncology

2002: Second Prize of the Military Science and Technology Progress Award

2005: Third Prize of the Military Science and Technology Progress Award

Member of Radiological Society of North America(RSNA)

Standing Member of Chinese Society of Radiology

Group Leader of the Group of Intervention of Chinese Journal of Radiology

Deputy Director Member of Chinese Society of Interventional Oncology

Director Member of Beijing Medical Association Society of Interventional Radiology

Deputy Chief Editor of Chinese Journal of Medical Image Technology

Standing Member of Professional Committee of Radiological Medicine of the Chinese People’s Liberation Army

Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

Awarded the Special Government Allowance of the State Council

Awarded three Second Prizes and four Third Prizes for Military Science and Technology Progress.

Awarded the honorary title of “Chinese College of Interventionalists(CCI) Master Interventionalist”

Led multiple national and provincial/ministerial scientific research projects, including two projects funded by the National Natural Science Foundation of China and two projects funded by the Department of Science and Technology of Sichuan Province.

In the pioneering development of interventional medicine in China, Zhang Jinshan has been an indispensable founder and leading figure. As China’s first overseas-trained doctoral graduate in radiological medicine, he returned to China in the 1980s after completing his studies abroad and introduced cutting-edge international interventional technologies to the country. Over more than four decades of dedicated practice and research, he has helped propel Chinese interventional medicine from its infancy to a position at the forefront of the global field through his exceptional clinical expertise and profound academic accomplishments.

Professor Zhang Jinshan has long been dedicated to the field of medical imaging and has developed distinctive expertise in selective and superselective interventional diagnosis and treatment for solid tumors such as liver cancer, demonstrating exceptional technical proficiency and profound academic accomplishment. Beginning in the 1990s, he led his team in pioneering the clinical application and research of TIPSS and B-ORTO in China, filling major gaps in the domestic field and opening new paths for the interventional management of gastrointestinal bleeding caused by portal hypertension secondary to liver cirrhosis. In addition, he has made groundbreaking contributions to the interventional diagnosis and treatment of peripheral vascular diseases, as well as to preoperative embolization for spinal tumors.

In the field of liver cancer treatment, Professor Zhang Jinshan not only led the development of standardized treatment protocols for liver cancer but also pioneered Transcatheter Arterial Chemoembolization with temporary Hepatic Vein Thrombosis (TACE-THVO) for primary liver cancer, bringing the efficacy of interventional therapy to a new level. In recognition of his outstanding clinical and scientific contributions, he was awarded the honorary title of “Chinese Master of Interventional Radiology” at the 2019 annual conference of the Chinese College of Interventionalists.

Professor Zhang Jinshan is not only a master clinician but also a driving force in the development of the discipline and a dedicated mentor in talent cultivation. He led his team in establishing one of China’s premier interventional therapy centers. As a doctoral supervisor, he has trained a large number of outstanding specialists and future leaders in interventional medicine, with many of his students and protégés now serving across the country. Academically, he has led multiple key national and military research projects, published more than 300 academic papers, and served as chief editor of three monographs, making remarkable contributions to the establishment of China’s academic framework for interventional medicine and the nationwide dissemination of its technologies.

From the laboratory to the operating room, and from academic podiums to grassroots hospitals, Professor Zhang Jinshan has consistently upheld the principles of “pioneering, innovation, pragmatism, and compassion". He has devoted his life to fulfilling the mission of a physician—relieving patients’ suffering through minimally invasive techniques and advancing the discipline through academic excellence—thereby establishing himself as a truly towering figure and one of the foremost authorities in the field of interventional medicine in China.

Professor Zhang Jinshan’s Academic Achievements

Professor Zhang Jinshan has achieved prolific academic accomplishments, having published over 300 academic papers covering areas such as interventional therapy for liver cancer, minimally invasive treatment of portal hypertension, interventional treatment of vascular diseases, and tumor ablation.

Selected Publications by Professor Zhang Jinshan

1. Zhang Jinshan, Wang Maoqiang. Experiments and Clinical Studies of transjugular intrahepatic portosystemic stent shunt (TIPSS). Chinese Journal of Radiology, 1993，27（6）：361-365.

Professor Zhang Jinshan is the first author. This is one of the early research papers in China that systematically elaborates on the TIPSS technique. Through animal experiments and clinical case analysis, it confirmed that TIPSS is a safe and effective minimally invasive method for treating portal hypertension and its complications, laying an important foundation for the promotion and application of this technique in China.

2.Zhang Jinshan, Li Huai. Clinical study on transcatheter arterial embolization with temporary hepatic vein occlusion for the treatment of primary liver cancer.Chinese Journal of Radiology, 1996，30（8）：521-524.

Professor Zhang Jinshan is the first author. He innovatively proposed the technique of "transcatheter arterial embolization with temporary hepatic vein occlusion." Clinical results demonstrated that this method can significantly increase the drug concentration within liver cancer lesions, reduce damage to normal liver tissue, and effectively improve the therapeutic outcomes for intermediate and advanced liver cancer, providing a novel strategy for the interventional treatment of liver cancer.

3. Zhang Jinshan, Wang Maoqiang, Li Huai. Interventional treatment of Budd-Chiari syndrome. Chinese Journal of Medical Imaging Technology, 1998，14（3）：189-191.

Professor Zhang Jinshan is the first author. This paper systematically summarizes the early experience in interventional treatment of Budd-Chiari syndrome in China, elaborating in detail on the key operational points and therapeutic efficacy of techniques such as percutaneous transluminal angioplasty and stent placement. It confirms that interventional therapy is the preferred minimally invasive method for Budd-Chiari syndrome, promoting the standardized development of treatment for this disease.

4.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical value of superselective hepatic arterial chemoembolization in the treatment of hypovascular liver cancer. Chinese Journal of Radiology, 2000，34（5）：335-337.

Professor Zhang Jinshan is the first author. Addressing the challenges in interventional treatment of hypovascular liver cancer, this paper explores the clinical efficacy of superselective hepatic arterial chemoembolization. The results indicate that this technique can precisely target the lesions and improve the treatment response rate, providing an important clinical basis for the interventional treatment of hypovascular liver cancer.

5. Zhang Jinshan, Li Huai, Wang Maoqiang. Interventional treatment of peripheral vascular stenosis and occlusion.Chinese Journal of Radiology, 2002，36（7）：612-614.

Professor Zhang Jinshan is the first author. This paper summarizes the interventional treatment experience of over 400 patients with peripheral vascular stenosis and occlusion, analyzing the indications and efficacy of techniques such as balloon angioplasty and stent placement. It confirms that interventional therapy is a safe and effective approach for peripheral vascular diseases, providing practical support for its clinical promotion.

6.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical application of CT-guided percutaneous puncture ablation in the treatment of abdominal tumors. Chinese Journal of Medical Imaging Technology, 2004，20（9）：1395-1397.

Professor Zhang Jinshan is the first author. This paper explores the application value of CT-guided percutaneous puncture techniques such as radiofrequency ablation and chemical ablation in the treatment of abdominal tumors. The clinical results show that this method is minimally invasive with reliable efficacy, offering a minimally invasive treatment option for patients with inoperable abdominal tumors.

7.Zhang Jinshan, Wang Maoqiang, Li Huai. Advances in the application of interventional therapy for benign prostatic hyperplasia. Chinese Journal of Radiology, 2006，40（8）：876-878.

Professor Zhang Jinshan is the corresponding author. This paper systematically reviews the cutting-edge advances in interventional therapy for benign prostatic hyperplasia, including the principles, procedures, and efficacy of techniques such as prostatic artery embolization and stent placement, providing new insights for the minimally invasive treatment of benign prostatic hyperplasia.

8.Zhang Jinshan, Li Huai, Wang Maoqiang. Discussion on the standardization of interventional therapy for liver cancer. Chinese Journal of Practical Surgery, 2008，28（10）：856-858.

Professor Zhang Jinshan is the corresponding author. Drawing on years of clinical experience and research findings, he led the discussion on standardized protocols for interventional therapy of liver cancer, covering key aspects such as preoperative assessment, treatment modality selection, and postoperative management, providing important references for the formulation of clinical guidelines for interventional therapy of liver cancer in China.

Professor Zhang Jinshan co-authored monographs

1. Interventional Radiology (People's Military Medical Press, 1995): The first monograph in China to systematically discuss the theories and techniques of interventional radiology. It comprehensively elaborates on the interventional diagnosis and treatment system for tumors, vascular diseases, and non-vascular diseases, becoming a classic essential textbook for interventional physicians in China.

2.Interventional Therapy for Liver Cancer (People's Health Press, 2001): Focusing on minimally invasive interventions for liver cancer, this book systematically summarizes techniques such as TACE, ablation, and vascular intervention, refines operational standards and the prevention and management of complications, and promotes the standardization of interventional therapy for liver cancer.

3.Interventional Treatment of Portal Hypertension (Science Press, 2005): This book systematically elaborates on minimally invasive techniques for portal hypertension, such as TIPSS and B-ORTO, covering experimental research, clinical procedures, long-term follow-up, and efficacy evaluation, filling the gap in monographs on interventional treatment of portal hypertension in China.

Professor Zhang Jinshan’s Research project

1.The National "Eighth Five-Year Plan" Scientific and Technological Key Project—Clinical and Basic Research on Comprehensive Interventional Therapy for Liver Cancer (Project Leader): This project systematically explored multimodal interventional strategies for liver cancer, established the core regimen of superselective TACE combined with local ablation, and significantly improved the therapeutic outcomes for intermediate and advanced liver cancer.

2.The Military "Ninth Five-Year Plan" Key Medical Scientific Research Project—Standardized Research on TIPSS for the Treatment of Portal Hypertension (Project Leader): This project formulated China's first operational standards and postoperative management guidelines for TIPSS, reduced the incidence of complications, and promoted the popularization of this technique throughout the military and across the country.

3.National Natural Science Foundation of China Project — Research on the Mechanism of Targeted Therapy for Liver Cancer Using Hepatic Vein Occlusion Combined with Chemoembolization (Project Leader): This project revealed the synergistic enhancement mechanisms of the innovative technique at the levels of hemodynamics, drug metabolism, and the tumor microenvironment, providing theoretical support for precision interventional therapy of liver cancer.

4.Military Clinical High-Tech Major Project-Establishment and Clinical Application of the Interventional Treatment Technology System for Complex Vascular Diseases (Project Leader): This project overcame interventional challenges in complex lesions such as Budd-Chiari syndrome, peripheral vascular occlusion, and vascular malformations, forming a complete technical system that has been promoted and applied widely.

Cirujano oncólogo certificado con enfoque en procedimientos de precisión en el Hospital Galenia.

• Especialista en cirugía oncológica con título de la Universidad Autónoma de México
• Certificado por el Conacem hasta 2030
• Miembro de la Sociedad Mexicana de Oncología (SMEO)
• Docente universitario en la Universidad Anáhuac desde 2020

El Dr. Albayrak se especializa en urología en el Hospital Universitario Medipol Mega.

• Experto en la realización de orquiectomías
• Trabaja en un hospital universitario líder
• Se centra en procedimientos quirúrgicos urológicos

Especialista en oncología médica con experiencia enfocada en terapias dirigidas para casos complejos de cáncer. El Dr. Valame se dedica tanto a la atención al paciente como al avance de la investigación oncológica.

• DNB en Oncología Médica del Hospital Indraprastha Apollo
• Presentó investigaciones en el Simposio de Cáncer Gastrointestinal de la ASCO
• Experto en las bases moleculares de los tratamientos contra el cáncer
• Ponente en la Escuela Internacional de Invierno de Oncología